Your browser doesn't support javascript.
loading
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.
Am Heart J ; 165(2): 109-15.e3, 2013 Feb.
Article in En | MEDLINE | ID: mdl-23351812

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pericardial Effusion / Pericarditis, Tuberculous / Prednisolone / Bacterial Vaccines / Pericardiocentesis / Immunotherapy / Mycobacterium Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2013 Document type: Article Affiliation country: Sudáfrica

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pericardial Effusion / Pericarditis, Tuberculous / Prednisolone / Bacterial Vaccines / Pericardiocentesis / Immunotherapy / Mycobacterium Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2013 Document type: Article Affiliation country: Sudáfrica